Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe revision indicator on the page changes from v3.6.1 to v3.6.3. This reflects a minor site version update.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.6.1 is now displayed, replacing v3.6.0. This update represents a minor page version upgrade that does not alter study content or results.SummaryDifference0.1%

- Check28 days agoChange DetectedRecruitment status note 'No longer looking for participants' was added, along with new navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and an 'Intervention/Treatment' heading; the revision tag changed from Revision: v3.5.5 to v3.6.0 and the 'Intervention / Treatment' heading formatting was removed.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, reflecting a small maintenance update to the page without changing study content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows a new revision tag, updating from v3.5.3 to v3.5.4, indicating a minor system update. The update does not alter the study details, eligibility criteria, or results presented on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows a revision tag v3.5.3, with the v3.5.2 tag removed. This reflects a deployment-level update to the page rather than a substantive content change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.